<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02704884</url>
  </required_header>
  <id_info>
    <org_study_id>394733</org_study_id>
    <nct_id>NCT02704884</nct_id>
  </id_info>
  <brief_title>Microbial Soy Milk Consumption, Inflammation and Renal Function Among Type 2 Diabetic Patients With Nephropathy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isfahan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Isfahan University of Medical Sciences</source>
  <brief_summary>
    <textblock>
      The aim of the present study was to determine the effects of fortified soy milk with L.
      planetarium A7 on a cytokine receptor, an adipokine and renal function biomarkers in type II
      diabetic patients with nephropathy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2016</start_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>inflammatory adipokine- Progranulin (PGRN)</measure>
    <time_frame>8 week</time_frame>
    <description>PGRN will determine by commercial sandwich enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's protocols. (Human ELISA kits, Shanghai Crystal Day Biotech Company, China).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cytokine receptor -soluble tumor necrosis factor receptor 1 (sTNFR1),</measure>
    <time_frame>8 week</time_frame>
    <description>sTNFR1 will determine by commercial sandwich enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's protocols. (Human ELISA kits, Shanghai Crystal Day Biotech Company, China).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>serum levels of Neutrophil gelatinase-associated lipocalin (NGAL)</measure>
    <time_frame>8 week</time_frame>
    <description>NGAL will determine by commercial sandwich enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's protocols. (Human ELISA kits, Shanghai Crystal Day Biotech Company, China).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cystatin C (Cys- C)</measure>
    <time_frame>8 week</time_frame>
    <description>Cys- C will determine by commercial sandwich enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer's protocols. (Human ELISA kits, Shanghai Crystal Day Biotech Company, China).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Type II Diabetic Patients With Nephropathy</condition>
  <arm_group>
    <arm_group_label>probiotic soy milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>consume a diet containing 200 ml/day probiotic soy milk in intervention group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>soy milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200 ml/day soy milk in the control condition</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>probiotic soy milk</intervention_name>
    <arm_group_label>probiotic soy milk</arm_group_label>
    <arm_group_label>soy milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults

          -  Type 2 diabetic patients with stages 1 and 2 of nephropathy (defined as meeting
             criteria including fasting blood glucose &gt;126 mg/dL, hypoglycemic agents, or insulin
             intake, proteinuria &gt;300 mg/day, and glomerular filtration rate &gt;90 mL/min)

        Exclusion Criteria:

          -  pregnancy or lactating in women

          -  allergy or intolerance to soy milk or avoidance of soy milk consumption

          -  smoking, alcoholism

          -  recent antibiotic therapy and using of supplements containing vitamins and minerals

          -  any medical condition such as inflammatory bowel disease, infection, liver disease and
             rheumatoid arthritis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>32 Years</minimum_age>
    <maximum_age>68 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Makan Pourmasoumi</name>
      <address>
        <city>Tehran</city>
        <zip>1353</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>August 11, 2016</last_update_submitted>
  <last_update_submitted_qc>August 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Isfahan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Makan Pourmasoumi</investigator_full_name>
    <investigator_title>MSc student, Principal Investigator, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

